Analyst Consensus ?
ConsensusBuy52 ratings
Bullish3873.1%
Neutral1426.9%
Bearish00.0%
FN2 Earnings Intelligence
Stryker Corporation complete analyst coverage
Stryker Corporation (SYK) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$275.56Current
$245Low
$358.49Average
$469High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 12, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Sep 10, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Sep 9, 2026 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Aug 13, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Aug 3, 2026 |
| Truist Securities | Hold | Hold | Maintain | Jul 31, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Jul 31, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 31, 2026 |
| BTIG | Buy | Buy | Maintain | Jul 31, 2026 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jul 9, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Jul 6, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Jun 5, 2026 |
| Barclays | Overweight | Overweight | Maintain | May 4, 2026 |
| Needham | Buy | Buy | Maintain | May 1, 2026 |
| Canaccord Genuity | Buy | Buy | Maintain | May 1, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Mar 17, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jan 9, 2026 |
| JMP Securities | Market Perform | Market Perform | Maintain | May 5, 2025 |
| Roth MKM | Buy | Buy | Maintain | May 2, 2025 |
| Stifel | Buy | Buy | Maintain | Jan 29, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Dec 2, 2024 |
| Baird | Outperform | Outperform | Maintain | Oct 30, 2024 |
| TD Cowen | Buy | Buy | Maintain | Apr 11, 2024 |
| B of A Securities | Buy | Neutral | Upgrade | Sep 5, 2023 |
| Argus Research | Buy | Buy | Maintain | May 25, 2023 |
| Jefferies | Buy | Buy | Maintain | May 2, 2023 |
| Deutsche Bank | Hold | Hold | Maintain | May 2, 2023 |
| Loop Capital | Buy | Buy | Maintain | Apr 17, 2023 |
| Edward Jones | Buy | Hold | Upgrade | Jul 28, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jul 22, 2022 |
| SVB Leerink | Outperform | Outperform | Maintain | Jan 28, 2022 |
| Oppenheimer | Perform | Perform | Maintain | Jul 28, 2021 |
| Northland Capital Markets | Outperform | Market Perform | Upgrade | Jul 28, 2021 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 28, 2021 |
| Raymond James | Outperform | Outperform | Maintain | Apr 28, 2021 |
| CFRA | Strong Buy | Strong Buy | Maintain | May 1, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jan 29, 2020 |
| Piper Jaffray | Overweight | Overweight | Maintain | Jul 26, 2019 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Jul 26, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Jan 31, 2018 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Apr 27, 2016 |
| Sterne Agee | Buy | Neutral | Upgrade | Apr 27, 2016 |
| Brean Capital | Buy | Hold | Upgrade | Jan 27, 2016 |
| Northland Securities | Market Perform | Outperform | Downgrade | Jan 7, 2016 |
| SunTrust Robinson Humphrey | Neutral | Reduce | Upgrade | Apr 14, 2014 |
| Wunderlich Securities | Hold | Buy | Downgrade | Jul 19, 2013 |
| Wunderlich | Hold | Buy | Downgrade | Jul 19, 2013 |
| Standpoint Research | Hold | Buy | Downgrade | Dec 18, 2012 |
| Bank of America | Buy | Buy | Maintain | Dec 12, 2012 |
| PiperJaffray | Neutral | Overweight | Downgrade | Aug 2, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $275.56. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| BMO Capital | Joanne Wuensch | $317 | $277.89 | +15.0% | Sep 9, 2026 |
| Wells Fargo | Larry Biegelsen | $348 | $276.43 | +26.3% | Sep 9, 2026 |
| RBC Capital | Shagun Singh | $420 | $321.08 | +52.4% | Jul 31, 2026 |
| Raymond James | Analyst unavailable | $370 | $322.69 | +34.3% | Jul 31, 2026 |
| BTIG | Ryan Zimmerman | $358 | $322.13 | +29.9% | Jul 31, 2026 |
| Piper Sandler | Analyst unavailable | $390 | $348.37 | +41.5% | Jul 31, 2026 |
| Wolfe Research | Analyst unavailable | $375 | $348.37 | +36.1% | Jul 31, 2026 |
| BTIG | Analyst unavailable | $371 | $329.78 | +34.6% | Jul 13, 2026 |
| Argus Research | Analyst unavailable | $370 | $328.79 | +34.3% | Jul 9, 2026 |
| BMO Capital | Analyst unavailable | $369 | $326.85 | +33.9% | Jul 8, 2026 |
| Evercore ISI | Analyst unavailable | $350 | $319.22 | +27.0% | Jul 6, 2026 |
| Leerink Partners | Mike Kratky | $407 | $301.21 | +47.7% | Jun 5, 2026 |
| Truist Financial | Richard Newitter | $330 | $293.44 | +19.8% | May 4, 2026 |
| Barclays | Matt Miksic | $394 | $294.73 | +43.0% | May 4, 2026 |
| Goldman Sachs | David Roman | $361 | $294.73 | +31.0% | May 1, 2026 |
| Bernstein | Analyst unavailable | $410 | $302.38 | +48.8% | May 1, 2026 |
| Robert W. Baird | Analyst unavailable | $385 | $307.87 | +39.7% | May 1, 2026 |
| Evercore ISI | Analyst unavailable | $355 | $308.17 | +28.8% | May 1, 2026 |
| BTIG | Analyst unavailable | $379 | $315.18 | +37.5% | May 1, 2026 |
| Needham | Analyst unavailable | $418 | $315.18 | +51.7% | May 1, 2026 |
| Deutsche Bank | Analyst unavailable | $315 | $315.18 | +14.3% | May 1, 2026 |
| Jefferies | Matthew Taylor | $465 | $381.89 | +68.7% | Mar 4, 2026 |
| UBS | Analyst unavailable | $400 | $381.83 | +45.2% | Feb 24, 2026 |
| Barclays | Analyst unavailable | $469 | $369.56 | +70.2% | Feb 2, 2026 |
| Needham | Mike Matson | $454 | $365.62 | +64.8% | Jan 30, 2026 |
| Robert W. Baird | Analyst unavailable | $437 | $369.02 | +58.6% | Jan 30, 2026 |
| BTIG | Ryan Zimmerman | $412 | $354.3 | +49.5% | Jan 30, 2026 |
| Bernstein | Lee Hambright | $465 | $367.21 | +68.7% | Jan 9, 2026 |
| Goldman Sachs | Analyst unavailable | $399 | $367.21 | +44.8% | Jan 9, 2026 |
| Raymond James | Analyst unavailable | $418 | $348.79 | +51.7% | Jan 6, 2026 |
| Evercore ISI | Analyst unavailable | $390 | $347.68 | +41.5% | Jan 5, 2026 |
| Truist Financial | Richard Newitter | $400 | $366.38 | +45.2% | Nov 14, 2025 |
| RBC Capital | Shagun Singh | $435 | $365.14 | +57.9% | Nov 14, 2025 |
| Needham | Mike Matson | $448 | $373.42 | +62.6% | Nov 14, 2025 |
| Truist Financial | Analyst unavailable | $392 | $359.36 | +42.3% | Nov 3, 2025 |
| Evercore ISI | Analyst unavailable | $405 | $357.6 | +47.0% | Oct 31, 2025 |
| Truist Financial | Analyst unavailable | $407 | $370.88 | +47.7% | Oct 15, 2025 |
| UBS | Analyst unavailable | $408 | $364.6 | +48.1% | Oct 13, 2025 |
| Evercore ISI | Analyst unavailable | $410 | $366.28 | +48.8% | Oct 7, 2025 |
| Redburn Partners | Analyst unavailable | $420 | $376.8 | +52.4% | Sep 18, 2025 |
| Truist Financial | Analyst unavailable | $415 | $381.49 | +50.6% | Aug 4, 2025 |
| Bernstein | Lee Hambright | $450 | $381.36 | +63.3% | May 5, 2025 |
| BTIG | Ryan Zimmerman | $403 | $353.42 | +46.2% | Apr 14, 2025 |
| Goldman Sachs | Analyst unavailable | $422 | $389.92 | +53.1% | Mar 4, 2025 |
| Argus Research | David Toung | $450 | $391.14 | +63.3% | Feb 3, 2025 |
| Truist Financial | Richard Newitter | $409 | $359.17 | +48.4% | Dec 18, 2024 |
| Morgan Stanley | Patrick Wood | $445 | $390.9 | +61.5% | Dec 2, 2024 |
| Citigroup | Joanne Wuensch | $411 | $363.43 | +49.2% | Oct 31, 2024 |
| Piper Sandler | Matt O'Brien | $420 | $367.95 | +52.4% | Oct 30, 2024 |
| Truist Financial | Richard Newitter | $380 | $365.42 | +37.9% | Oct 30, 2024 |
| Canaccord Genuity | Kyle Rose | $400 | $359.01 | +45.2% | Oct 30, 2024 |
| BTIG | Ryan Zimmerman | $394 | $359.01 | +43.0% | Oct 30, 2024 |
| Truist Financial | Richard Newitter | $370 | $356.45 | +34.3% | Oct 14, 2024 |
| Piper Sandler | Matt O\'Brien | $380 | $365.22 | +37.9% | Sep 10, 2024 |
| BTIG | Ryan Zimmerman | $374 | $358.51 | +35.7% | Aug 28, 2024 |
| Truist Financial | Richard Newitter | $345 | $327 | +25.2% | Aug 1, 2024 |
| BTIG | Ryan Zimmerman | $360 | $330.22 | +30.6% | Jul 31, 2024 |
| Goldman Sachs | David Roman | $372 | $341.14 | +35.0% | May 30, 2024 |
| Argus Research | David Toung | $380 | $330.51 | +37.9% | May 22, 2024 |
| Needham | Mike Matson | $392 | $330.51 | +42.3% | May 22, 2024 |
| BTIG | Ryan Zimmerman | $366 | $342.05 | +32.8% | Apr 15, 2024 |
| Piper Sandler | Matt O'Brien | $280 | $253.81 | +1.6% | Jan 31, 2023 |
| Morgan Stanley | Analyst unavailable | $260 | $254.93 | -5.6% | Jan 6, 2023 |
| BTIG | Ryan Zimmerman | $268 | $239.65 | -2.7% | Dec 21, 2022 |
| Cowen & Co. | Cowen Cowen | $283 | $239.84 | +2.7% | Dec 19, 2022 |
| Barclays | Analyst unavailable | $257 | $238.76 | -6.7% | Dec 2, 2022 |
| Piper Sandler | Matt O’Brien | $260 | $206.93 | -5.6% | Sep 24, 2022 |
| BTIG | Analyst unavailable | $238 | $202.61 | -13.6% | Sep 6, 2022 |
| BTIG | Analyst unavailable | $244 | $192.91 | -11.5% | Jul 18, 2022 |
| Stifel Nicolaus | Analyst unavailable | $245 | $193.26 | -11.1% | Jul 18, 2022 |
| Argus Research | David Toung | $270 | $232.41 | -2.0% | May 23, 2022 |
| Truist Financial | Richard Newitter | $280 | $236.97 | +1.6% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $270 | $236.97 | -2.0% | May 2, 2022 |
| Piper Sandler | Matt O’Brien | $290 | $241.26 | +5.2% | Apr 30, 2022 |
| Wells Fargo | Analyst unavailable | $286 | $246.64 | +3.8% | Apr 29, 2022 |
| BTIG | Ryan Zimmerman | $278 | $276.37 | +0.9% | Apr 21, 2022 |
| RBC Capital | Shagun Singh | $272 | $261.7 | -1.3% | Apr 16, 2022 |
| Bernstein | Lee Hambright | $295 | $267.34 | +7.1% | Mar 19, 2022 |
| Bank of America Securities | Travis Steed | $300 | $266.47 | +8.9% | Mar 3, 2022 |
| J.P. Morgan | Robbie Marcus | $265 | $247.76 | -3.8% | Jan 28, 2022 |
| UBS | Matthew Taylor | $267 | $247.76 | -3.1% | Jan 28, 2022 |
| BTIG | Ryan Zimmerman | $273 | $247.76 | -0.9% | Jan 28, 2022 |
| Leerink Partners | Danielle Antalffy | $285 | $247.76 | +3.4% | Jan 28, 2022 |
| Piper Sandler | Matthew O'Brien | $315 | $244.7 | +14.3% | Jan 27, 2022 |
| Deutsche Bank | Pito Chickering | $285 | $254.03 | +3.4% | Jan 21, 2022 |
| Motley Fool | Rick Aristotle Munarriz | $278 | $259.21 | +0.9% | Dec 9, 2021 |
| Loop Capital Markets | Jason Wittes | $305 | $253.11 | +10.7% | Dec 6, 2021 |
| Argus Research | David Toung | $320 | $267.18 | +16.1% | Jul 29, 2021 |
| Canaccord Genuity | Kyle Rose | $290 | $266.68 | +5.2% | Jul 28, 2021 |
| Cowen & Co. | Josh Jennings | $305 | $266.68 | +10.7% | Jul 28, 2021 |
| Credit Suisse | Matt Miksic | $311 | $266.68 | +12.9% | Jul 28, 2021 |
| Oppenheimer | Steven Lichtman | $288 | $266.68 | +4.5% | Jul 28, 2021 |
Track every rating change on SYK the moment it posts. Free to start.
Start free